Morten Schou - Concepedia

Author

Morten Schou

Also Known As

Helena Dominguez, M S Morten Schou, M S Schou, M SCHOU, M Schou, M. Schou, M., Schou, M.S Schou, MORTEN SCHOU, Michal Vrablík

355

Publications

12.1K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Gentofte Hospital University of Copenhagen Copenhagen University Hospital Herlev Hospital

About

Morten Schou is an author at Rigshospitalet specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	31	3.1K
2	Public Health	8	8	226
3	Health Sciences	6	6	409
4	Applied Physiology	2	2	90
5	Cardiothoracic Surgery	2	2	82

Morten Schou

129

Publications

10.4K

Citations

H-Index

Page 1

	Year	Citations
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink, Nature Medicine	2022	814
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan, New England Journal of Medicine	2024	530
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial Anders Jorsal, Caroline Kistorp, Pernille Holmager, European Journal of Heart Failure	2016	521
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Mikhail Kosiborod, Mark C. Petrie, Barry A. Borlaug, New England Journal of Medicine	2024	520
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials Javed Butler, Sanjiv J. Shah, Mark C. Petrie, The Lancet ObesityMetabolic SyndromeNon-pharmacological InterventionHeart FailureCardiovascular Disease	2024	275
Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction Daniel Modin, Brian Claggett, Caroline Sindet‐Pedersen, Circulation	2020	255
Incidence of Cancer in Patients with Chronic Heart Failure: A Long-Term Follow-Up Study Ann Banke, Morten Schou, Lars Videbæk, European Journal of Heart Failure	2016	227
Empagliflozin after Acute Myocardial Infarction Javed Butler, W. Schuyler Jones, Jacob A. Udell, New England Journal of Medicine	2024	223
Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction Massar Omar, J. Steen Jensen, Mulham Ali, JAMA Cardiology	2021	177

Page 1